InvestorsHub Logo
Followers 9
Posts 152
Boards Moderated 0
Alias Born 01/10/2022

Re: theswordman post# 210985

Thursday, 06/23/2022 7:11:33 AM

Thursday, June 23, 2022 7:11:33 AM

Post# of 232882
Isn't that the one where the SEC weirdly said the FDA wouldn't be happy with Cytodyn saying leronlimab worked in it's quarterly filings because they hadn't gotten the drug approved yet? They addressed that although, technically, they were within their rights to report their interpretation of the outcome of the study. They weren't making false claims about efficacy to patients. That stuff was used to take down some hemp gummy websites. It was dumb to try to apply it to leronlimab
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News